TriClip Japan Post-Approval Study
ConditionTricuspid Regurgitation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAbbott Medical Devices
About this trial
The goal of this observational post approval study is to confirm the safety and efficacy of the TriClip System when used in routine clinical practice in the Japanese population and to fulfill post-market requirements following commercial approval in Japan.
Eligibility criteria
Qualifiers
Subjects are eligible to receive the TriClip System per the current approved indications for use (IFU)
Subjects provide written informed consent prior to conducting any investigation-specific procedures not considered standard of care.
Disqualifiers
There are no exclusion criteria
Please note: It is not recommended that subjects enrolled in the study participate in any other therapeutic clinical study.
Trial design
Treatments tested in this trial
- The TriClip System
Treatment groups
250 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov